- Search for Research Summaries, Reviews, and Reports
- EPC Project
Related Products for this Topic
- Executive Summary Jan. 24, 2007
Research Review - Final – Jan. 24, 2007
Comparative Effectiveness of Second-Generation Antidepressants in the Pharmacologic Treatment of Adult Depression
- Final Report (PDF) 1.2 MB
- Report Appendixes (PDF) 2.4 MB
- Web Version (NLM Site)
- Help with Viewers, Players, and Plug-ins
Archived: This report has been updated.
People using assistive technology may not be able to fully access information in these files. For additional assistance, please contact us.
This report summarizes the available evidence on the comparative efficacy, effectiveness, and harms of 12 second-generation antidepressants: bupropion, citalopram, duloxetine, escitalopram, fluoxetine, fluvoxamine, mirtazapine, nefazodone, paroxetine, sertraline, trazodone, and venlafaxine in treating patients with MDD, dysthymia, and subsyndromal depression. It also evaluates the comparative efficacy and effectiveness for maintaining remission and for treating accompanying symptoms such as anxiety, insomnia, or neurovegetative symptoms.